Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 7;10(1):4.
doi: 10.1186/s40345-022-00249-5.

Estimated glomerular filtration rate in Korean patients exposed to long-term lithium maintenance therapy

Yunji Cho  1 , Dongbin Lee  1   2 , Ji Hyun Baek  3 , Kyung Sue Hong  1   4
Affiliations

Estimated glomerular filtration rate in Korean patients exposed to long-term lithium maintenance therapy

Yunji Cho et al. Int J Bipolar Disord. .

Abstract

Background: Lithium-induced nephrotoxicity has long been debated. However, it has been rarely explored in Asian populations. The aim of the present study was to assess the effect of lithium maintenance therapy on estimated glomerular filtration rate (eGFR) in Korean patients diagnosed with a psychiatric illness.

Methods: This was a single-centered, retrospective study that included patients treated with lithium or comparator drug (valproate) in Samsung Seoul Medical Center between November 1994 and July 2020. Patients diagnosed with ICD codes F20-33 who had ≥ 6 months of exposure to lithium or valproate were included. Patients had to have ≥ 1 baseline and ≥ 2 post-baseline eGFR data with post-baseline data having an interval of at least 30 days. Chronic kidney disease (CKD) was defined as CKD stage 3 (eGFR < 60 mL/min/1.732). To be considered as CKD, the threshold had to be met at two consecutive post-baseline measurements. Those treated with both lithium and valproate, diagnosed with CKD stages 3-5, diagnosed with a renal disease, or received kidney transplantation were excluded.

Results: A total of 766 patients were included (242 treated with lithium and 524 with valproate). Two (0.8%) in the lithium group and 8 (1.5%) in the valproate group developed CKD stage 3. None developed CKD stages 4-5. Median yearly eGFR change was - 1.3 mL/min/1.732 (IQR: - 6.8, 1.7) for the lithium group and - 1.1 mL/min/1.732 (IQR: - 4.5, 1.5) for the valproate group, showing no significant difference between the two groups (p = 0.389). The rate of decline was more rapid for those with CKD in both groups. eGFR values of lithium and valproate groups did not show significant differences during a follow-up duration of 15 years or more. A significant negative correlation between baseline eGFR and yearly eGFR change was identified in a linear regression analysis.

Conclusions: In Korean patients, treatment with lithium did not increase the risk of developing CKD compared to treatment with valproate. Prevalence of CKD was lower than those previously reported in western populations. Low baseline eGFR showed significant correlation with changes in renal function.

Keywords: Bipolar disorder; Chronic kidney disease; Estimated glomerular filtration rate; Lithium; Lithium-induced nephrotoxicity; Renal function; Valproate.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Inclusion of the study group
Fig. 2
Fig. 2
Scatter plot of eGFR over follow-up period
Fig. 3
Fig. 3
Kaplan–Meier plot on years of treatment taken to enter CKD stage 3 (eGFR  < 60 mL/min/1.73 m2)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Aiff H, Attman PO, Aurell M, Bendz H, Schon S, Svedlund J. End-stage renal disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol. 2014;24(4):540–544. doi: 10.1016/j.euroneuro.2014.01.002. - DOI - PubMed
    1. Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schon S, et al. Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol. 2015;29(5):608–614. doi: 10.1177/0269881115573808. - DOI - PubMed
    1. Aurell M, Svalander C, Wallin L, Alling C. Renal function and biopsy findings in patients on long-term lithium treatment. Kidney Int. 1981;20(5):663–670. doi: 10.1038/ki.1981.191. - DOI - PubMed
    1. Baek JH, Ha K, Yatham LN, Chang JS, Ha TH, Jeon HJ, et al. Pattern of pharmacotherapy by episode types for patients with bipolar disorders and its concordance with treatment guidelines. J Clin Psychopharmacol. 2014;34(5):577–587. doi: 10.1097/JCP.0000000000000175. - DOI - PubMed
    1. Barbour SJ, Er L, Djurdjev O, Karim M, Levin A. Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients. Nephrol Dial Transplant. 2010;25(11):3663–3672. doi: 10.1093/ndt/gfq189. - DOI - PubMed